Healthia Ltd
ASX:HLA
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.79
1.795
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HLA stock under the Base Case scenario is 1.689 AUD. Compared to the current market price of 1.795 AUD, Healthia Ltd is Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Healthia Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Healthia Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Healthia Ltd
Balance Sheet Decomposition
Healthia Ltd
Current Assets | 36.8m |
Cash & Short-Term Investments | 5.6m |
Receivables | 13.2m |
Other Current Assets | 18.1m |
Non-Current Assets | 359.1m |
Long-Term Investments | 21k |
PP&E | 85m |
Intangibles | 267.3m |
Other Non-Current Assets | 6.8m |
Current Liabilities | 52.3m |
Accounts Payable | 15.5m |
Accrued Liabilities | 10.3m |
Short-Term Debt | 2m |
Other Current Liabilities | 24.5m |
Non-Current Liabilities | 190.5m |
Long-Term Debt | 145.9m |
Other Non-Current Liabilities | 44.7m |
Earnings Waterfall
Healthia Ltd
Revenue
|
252.6m
AUD
|
Cost of Revenue
|
-20.6m
AUD
|
Gross Profit
|
231.9m
AUD
|
Operating Expenses
|
-202.1m
AUD
|
Operating Income
|
29.9m
AUD
|
Other Expenses
|
-24.4m
AUD
|
Net Income
|
5.5m
AUD
|
Free Cash Flow Analysis
Healthia Ltd
AUD | |
Free Cash Flow | AUD |
HLA Profitability Score
Profitability Due Diligence
Healthia Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Healthia Ltd's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
HLA Solvency Score
Solvency Due Diligence
Healthia Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Score
Healthia Ltd's solvency score is 26/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HLA Price Targets Summary
Healthia Ltd
Dividends
Current shareholder yield for HLA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
HLA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Healthia Ltd. is a holding company engages in the operation and expansion of podiatry and physiotherapy clinics, and Business-to-Business businesses in Australia. The company is headquartered in Bowen Hills, Queensland. The company went IPO on 2018-09-11. The company operates an integrated portfolio of health businesses, which include My FootDr, Allsports Physiotherapy, Extend Rehabilitation, iOrthotics and DBS Medical Supplies. My FootDr Podiatry Clinics has over 103 podiatry clinics and shoe stores that is engaged in footwear retailing. Allsports Physiotherapy provides physiotherapy services throughout Brisbane. Extend Rehabilitation provides therapies for hand and upper arm. Its iOrthotics manufactures orthotic design software, 3D printing and other technologies and provides orthotic solutions for over 100 podiatry clinics in Australia. DBS Medical Supplies provide supplies to podiatrists, hospitals, medical centers, nursing homes and allied health professionals throughout Australia, as well as New Zealand, the South Pacific and Hong Kong. DBS offer a range of products including podiatry equipment, surgical instruments, orthotic materials, clinic consumables and foot and nail care products.
Contact
IPO
Employees
Officers
The intrinsic value of one HLA stock under the Base Case scenario is 1.689 AUD.
Compared to the current market price of 1.795 AUD, Healthia Ltd is Overvalued by 6%.